ResultsIQ

ResultsIQ › Latest results › Kuantum Papers Limited

Kuantum Papers Limited strategy deck summary

NSE: KUANTUM · BSE: 532937

Strategy deck of 5 Sep 2025, summarised by AI from the filing.

Kuantum Papers reports Q1 FY26 operational income ₹2,229 mn, EBITDA ₹404 mn and PAT ₹121 mn, with 100% capacity utilization.

Key takeaways

  1. Q1 FY26 result Operational income ₹2,229 mn, EBITDA ₹404 mn (margin 18.12%), PAT ₹121 mn (margin 5.43%).
  2. Guidance Aims to produce 1 crore clones annually, covering 50,700 acres by 2028-29.
  3. Change FY25 operational income ₹11,070 mn vs FY24 ₹12,113 mn; EBITDA margin 21.92% vs 27.49%.
  4. Driver Increased paper production capacity to 450 TPD, fully absorbed by demand pull, operating at 100% utilization.
  5. Risk Significant imports from ASEAN, Japan and China due to FTAs have led to stagnation in paper export growth.

Original filing on BSE

Kuantum Papers Limited Q1 FY27 results

As filed: Revenue ₹304 cr (+36% year on year), EBITDA ₹40.1 cr (0% year on year), PAT ₹6.2 cr (−48% year on year), EBITDA margin 13.2% (−474 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹301 cr (+9% year on year), EBITDA ₹47.8 cr (−20% year on year), PAT ₹14.3 cr (−45% year on year), EBITDA margin 15.9% (−576 bps). Score 41 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 576 bps year on year. Share price after the results: −2.4% in 30 days (Nifty 500: +0.9%).
  • Q3 FY26: Revenue ₹290 cr (+7% year on year), EBITDA ₹39.3 cr (−23% year on year), PAT ₹9.8 cr (−53% year on year), EBITDA margin 13.6% (−534 bps). Score 41 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 534 bps year on year. Share price after the results: −7.3% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹280 cr (0% year on year), EBITDA ₹34.0 cr (−43% year on year), PAT ₹6.0 cr (−80% year on year), EBITDA margin 12.1% (−936 bps). Score 24 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 936 bps year on year. Profit fell 50% from last quarter. Share price after the results: −9.7% in 28 days (Nifty 500: +1.3%).
  • Q1 FY26: Revenue ₹223 cr (−21% year on year), EBITDA ₹40.0 cr (−44% year on year), PAT ₹12.0 cr (−68% year on year), EBITDA margin 17.9% (−769 bps). Score 7 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 769 bps year on year. Revenue fell 19% from last quarter. Share price after the results: −12.2% in 28 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹277 cr (−7% year on year), EBITDA ₹60.0 cr (−5% year on year), PAT ₹26.0 cr (−24% year on year), EBITDA margin 21.7% (+59 bps). Score 32 of 100, Below trend. Revenue and profit growth were well below the company's own trend; EBITDA growth was below it. EBITDA margin rose 59 bps year on year. Share price after the results: +1.8% in 30 days (Nifty 500: +0.8%).
  • Q3 FY25: Revenue ₹270 cr (−10% year on year), EBITDA ₹51.0 cr (−35% year on year), PAT ₹21.0 cr (−50% year on year), EBITDA margin 18.9% (−702 bps). Score 12 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 702 bps year on year. Revenue fell 3% from last quarter.
  • Q2 FY25: Revenue ₹279 cr (−6% year on year), EBITDA ₹60.0 cr (−24% year on year), PAT ₹30.0 cr (−30% year on year), EBITDA margin 21.5% (−509 bps). Score 12 of 100, Below trend. EBITDA margin fell 509 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 21% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Kuantum Papers Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.